Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study
ALL survivors have an increased risk of MetS compared with controls, essentially driven by the patients treated with TBI. The MetS frequency in non-TBI patients is equal to controls, but non-TBI patients more often have one or two components of Mets. ALL survivors seem slightly more insulin-resistant than controls.
Authors
- Thomas Leth Frandsen (ORCID: https://orcid.org/0000-0001-8495-5274)
- Niels Birkebæk (ORCID: https://orcid.org/0000-0001-6268-6464)
- Liv Andrés‐Jensen (ORCID: https://orcid.org/0000-0003-3437-8338)
- Mette Tiedemann Skipper (ORCID: https://orcid.org/0000-0002-6281-4814)
- Rikke Beck Jensen (ORCID: https://orcid.org/0000-0002-4522-672X)
- Peder Skov Wehner (ORCID: https://orcid.org/0000-0003-3881-5179)
- Ruta Tuckuviene (ORCID: https://orcid.org/0009-0007-2024-0553)
- Birgitte Klug Albertsen (ORCID: https://orcid.org/0000-0002-3902-3694)
- Kjeld Schmiegelow (ORCID: https://orcid.org/0000-0002-0829-4993)
- Bente Lomholt Langdahl
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1002/pbc.31705
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Aarhus Universitet
- Kræftens Bekæmpelse
- Shandong University
- Parker Institute for Cancer Immunotherapy
- Farmer of Oelufgaard Memorial Foundation
- Odense Universitetshospital
- NordForsk
- Dansk Kræftforsknings Fond
- Region Midtjylland